Skip to main content

Table 4 Detail characteristics of 19 hospitalized children with severe Adv. Pneumonia receiving ECMO

From: Impact of extracorporeal membrane oxygenation in immunocompetent children with severe adenovirus pneumonia

No.

Duration of IMV (days)

Duration from onset of illness to ECMO (days)

Duration of ECMO (days)

Duration of ICU (days)

Duration of hospitalization (days)

Main complications

Pre-ECMO arterial blood gas analysis

Pre-ECMO weaning arterial blood gas analysis

Post ECMO weaning arterial blood gas analysis

Outcomes

PaO2 (kPa)

PaCO2 (kPa)

FiO2

P/F

PaO2 (kPa)

PaCO2 (kPa)

FiO2

P/F

PaO2 (kPa)

PaCO2 (kPa)

FiO2

P/F

1

12

22

7

15

26

ARDS,Septic shock

11.50

4.00

100%

86.25

24.00

5.60

40%

450.00

20.00

5.90

50%

300.00

Survival

2

19

23

7

23

38

ARDS,Septic shock

7.60

4.10

100%

57.00

14.30

4.30

40%

268.13

13.30

4.90

50%

199.50

Survival

3

90

26

12

93

93

Pneumothorax,ARDS,Septic shock

7.16

4.96

100%

53.70

12.80

6.10

70%

137.14

NA

NA

NA

NA

Death

4

27

21

12

45

71

ARDS,Septic shock

6.90

5.10

100%

51.75

8.50

5.30

90%

70.83

10.90

5.50

70%

116.79

Survival

5

13

11

4

17

21

ARDS,Septic shock

7.50

5.90

90%

62.50

11.40

4.60

45%

190.00

12.30

4.90

50%

184.50

Survival

6

26

35

13

39

39

ARDS,Septic shock

9,6

4.70

100%

72.00

10.40

8.00

30%

260.00

8.40

7.30

60%

105.00

Death

7

7

18

3

14

27

ARDS,Septic shock

4.90

5.50

100%

36.75

12.40

4.60

50%

186.00

13.00

5.90

55%

177.27

Survival

8

14

9

8

27

46

Pneumothorax,ARDS,Septic shock

5.70

6.70

100%

42.75

18.30

5.90

55%

249.55

16.30

5.00

50%

244.50

Survival

10

18

16

11

23

28

ARDS,Septic shock

8.70

5.30

100%

65.25

14.90

5.50

48%

232.81

13.20

4.90

45%

220.00

Survival

11

7

10

6

7

7

Septic shock

5.20

7.90

100%

39.00

16.10

5.90

30%

402.50

NA

NA

NA

NA

Death

12

14

10

13

14

14

Acute renal failure, Pneumorrhagia, Gastrointestinal hemorrhage

4.10

5.50

100%

30.75

7.20

6.10

50%

108.00

8.20

7.10

60%

102.50

Death

13

6

8

3

6

6

Pleural effusion, ARDS, Septic shock,Liver failure,Acute renal failure

2.10

13.20

100%

15.75

5.50

6.80

50%

82.50

6.20

6.50

65%

71.54

Death

14

10

9

4

17

23

Pleural effusion,Septic shock

7.50

4.50

100%

56.25

9.80

5.20

45%

163.33

11.90

4.80

50%

178.50

Survival

15

17

7

10

24

29

Pleural effusion, ARDS,

8.90

3.20

100%

66.75

17.70

7.60

45%

295.00

17.70

6.50

60%

221.25

Survival

16

17

10

8

25

31

Pleural effusion, ARDS,Pneumorrhagia

10.70

3.60

100%

80.25

12.90

4.40

60%

161.25

12.90

4.50

55%

175.91

Survival

17

42

16

36

45

45

Pleural effusion, ARDS,Acute renal failure

9.89

4.46

100%

74.18

7.30

6.40

55%

99.55

6.30

7.80

60%

78.75

Death

18

28

13

16

33

33

Pleural effusion, ARDS,Septic shock Heart failure,Liver failure,

Acute renal failure

15.90

4.90

100%

119.25

8.70

4.40

80%

81.56

7.20

6.80

80%

67.50

Death

19

18

31

9

28

46

ARDS,Septic shock

10.40

5.60

100%

78.00

14.00

5.90

40%

262.50

13.10

5.70

50%

196.50

Survival

  1. P < 0.05 are shown in bold
  2. NA Patients NO.3 and NO.11 died before ECMO weaning because of some severe ECMO complications